ShareValue scores for 019175.KO: Valuation 29, Quality 53, Growth 34, Health 53.

Shinpoong Pharmaceutical Co Ltd logo

019175.KO
KRX

Shinpoong Pharmaceutical Co Ltd

₩12,880.00(+6.36%)
Loading chart...
Sentiment

Verdicts

Rating

Trap Risk

Return

-7% to 9%
Valuation
29
Overvalued
Price vs Value
Quality
53
Moderate
Business Strength
Growth
34
Weak
Revenue & Earnings
Health
53
Moderate
Financial Stability
Momentum
23
Bearish
Price Trend

Company Details

About

Shinpoong Pharmaceutical Co.,Ltd, together with its subsidiaries, manufactures and sells pharmaceutical products in South Korea. The company offers cephalosporin antibiotics; penicillin antibiotics; and finished products, as well as antivirals, anticancer drugs, painkillers, anti-inflammatory products, and anthelmintics. It provides active pharmaceutical ingredients; Pyramax, an anti-malarial drug; and drugs for treating hypercholesterolemia, knee osteoarthritis and shoulder periarthritis, and surgical adhesion barrier; prescription drugs; wound dressings; health functional food; and over the counter products. In addition, the company engages in business management and exports its products to approximately 50 countries. The company was founded in 1962 and is headquartered in Seoul, South Korea.

Score Analysis

AI Investment Thesis

Data as of:Aug 7, 2026
|
Last calculated:Aug 7, 2026